Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: Clinicopathologic features of 12 cases

Pei Lin, Adnan Mansoor, Carlos Bueso-Ramos, Suyang Hao, Raymond Lai, L. Jeffrey Medeiros

Research output: Contribution to journalArticlepeer-review

74 Scopus citations

Abstract

Of 92 patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) treated at our institution, diffuse large B-cell lymphoma (DLBCL) also developed in 12 (13%). In 10 patients, DLBCL developed 12 to 128 months (median, 44 months) after the diagnosis of LPL/WM. Two patients had LPL/WM and DLBCL simultaneously. Clinicopathologic features at diagnosis of LPL/WM did not predict the risk of DLBCL. Onset of DLBCL was characterized by worsening constitutional symptoms, profound cytopenias, extramedullary disease, and organomegaly. Immunoglobulin light chain expression was identical in both LPL/WM and DLBCL. In situ hybridization for Epstein-Barr virus (EBV) in 8 cases of DLBCL was negative. Of 11 patients with clinical follow-up information available, 8 (73%) died within 10 months of diagnosis of DLBCL, DLBCL, most likely as a result of histologic transformation, occurs in a subset of patients with LPL/WM and is associated with aggressive clinical course and poor outcome. EBV is unlikely to be involved in transformation.

Original languageEnglish (US)
Pages (from-to)246-253
Number of pages8
JournalAmerican Journal of Clinical Pathology
Volume120
Issue number2
DOIs
StatePublished - Aug 1 2003

Keywords

  • Large cell lymphoma
  • Lymphoplasmacytic lymphoma
  • Waldenström macroglobulinemia

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint

Dive into the research topics of 'Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: Clinicopathologic features of 12 cases'. Together they form a unique fingerprint.

Cite this